Titan amends amalgamation agreement with conavi medical inc.

Toronto, ontario, july 05, 2024 (globe newswire) -- titan medical inc. (“titan”) (tsx: tmd; otc: tmdif) announces that it has entered into a second amending agreement dated july 5, 2024 (the “amending agreement”), in respect of the previously announced amalgamation agreement dated march 17, 2024, as initially amended by an amending agreement on may 28, 2024 (collectively the “amalgamation agreement”) among conavi medical inc. (“conavi”), 1000824255 ontario inc. (a wholly-owned subsidiary of titan) and titan, to result in the merger of conavi and titan (the “proposed transaction”). in addition, titan is seeking an additional extension with the toronto stock exchange (“tsx”) to hold its annual general and special meeting of shareholders (the “agm”) on or before september 30, 2024. an update regarding titan's agm and any extension granted by the tsx will be provided at a later date.
AGMH Ratings Summary
AGMH Quant Ranking